The naturally acquired immunity in severe malaria and its implication for a PfEMP-1 based vaccine

Microbes and Infection

Volumn 9, Issue 6, 2007, Pages 777-783

  Chen, Qijun ^a,b  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Antigen; Immunity; Malaria; PfEMP1

Indexed keywords

CELL MEMBRANE PROTEIN; CYSTEINE DERIVATIVE; DUFFY BINDING PROTEIN; MALARIA VACCINE; PLASMODIUM FALCIPARUM ERYTHROCYTE MEMBRANE PROTEIN 1; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ADAPTIVE IMMUNITY; ANTIGEN EXPRESSION; ANTIGENIC VARIATION; DISEASE SEVERITY; DRUG DESIGN; DRUG TARGETING; ERYTHROCYTE MEMBRANE; HOST PARASITE INTERACTION; HUMAN; IMMUNOMODULATION; IMMUNOREACTIVITY; MALARIA; MOLECULAR INTERACTION; NONHUMAN; PARASITE VIRULENCE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN DOMAIN; SHORT SURVEY;

ANIMALS; ANTIGENS, PROTOZOAN; HUMANS; IMMUNITY, ACTIVE; MALARIA VACCINES; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PROTEIN STRUCTURE, TERTIARY; PROTOZOAN PROTEINS;

PLASMODIUM FALCIPARUM;

EID: 34247538414     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.02.009     Document Type: Short Survey

References (51)

1. Marsh K. Clinical Features of Malaria. In: Wahlgren M., and Perlmann P. (Eds). Malaria-Molecular and Clinical Aspects (1999), Harwood Academic Publishers 87-118
2. Fried M., Nosten F., Brockman A., Brabin B.J., and Duffy P.E. Maternal antibodies block malaria. Nature 395 (1989) 851-852
3. Bull P.C., and Marsh K. The role of antibodies to Plasmodium falciparum-infected-erythrocyte surface antigens in naturally acquired immunity to malaria. Trends Microbiol. 10 (2002) 55-58
4. Ndungu F.M., Urban B.C., Marsh K., and Langhorne J. Regulation of immune response by Plasmodium-infected red blood cells. Parasite Immunol. 27 (2005) 373-384
5. Gupta S., Snow R.W., Donnelly C.A., Marsh K., and Newbold C. Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat. Med. 5 (1999) 340-343
6. McGregor I.A. Malaria immunity: current trends and perspects. Ann. Trop. Med. Parasitol. 81 (1987) 647-656
7. Hviid L., and Staalsoe T. Malaria immunity in infants: a special case of a general phenomenon?. Trends Parasitol. 20 (2004) 66-72
8. Bull P.C., Lowe B.S., Kortok M., and Marsh K. Antibody recognition of Plasmodium falciparum erythrocyte surface antigens in Kenya: evidence for rare and prevalent variants. Infect. Immun. 67 (1999) 733-739
9. Carlson J., Helmby H., Hill A.V., Brewster D., Greenwood B.M., and Wahlgren M. Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 336 (1990) 1457-1460
10. Treutiger C.J., Hedlund I., Helmby H., Carlson J., Jepson A., Twumasi P., Kwiatkowski D., Greenwood B.M., and Wahlgren M. Rosette formation in Plasmodium falciparum isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria. Am. J. Trop. Med. Hyg. 46 (1992) 503-510
11. Rowe A., Obeiro J., Newbold C.I., and Marsh K. Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect. Immun. 63 (1995) 2323-2326
12. Heddini A., Pettersson F., Kai O., Shafi J., Obiero J., Chen Q., Barragan A., Wahlgren M., and Marsh K. Fresh isolates from children with severe Plasmodium falciparum malaria bind to multiple receptors. Infect. Immun. 69 (2001) 5849-5856
13. Rowe J.A., Moulds J.M., Newbold C.I., and Miller L.H. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 388 (1997) 292-295
14. Chen Q., Barragan A., Fernandez V., Sundstrom A., Schlichtherle M., Sahlen A., Carlson J., Datta S., and Wahlgren M. Identification of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as the rosetting ligand of the malaria parasite P. falciparum. J. Exp. Med. 187 (1998) 15-23
15. Vogt A.M., Barragan A., Chen Q., Kironde F., Spillmann D., and Wahlgren M. Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1alpha domain of PfEMP1. Blood 101 (2003) 2405-2411
16. Chen A., Heddini A., Barragan A., Fernandez V., Pearce S.F., and Wahlgren M. The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors. J. Exp. Med. 192 (2000) 1-10
17. Fernandez V., Treutiger C.J., Nash G.B., and Wahlgren M. Multiple adhesive phenotypes linked to rosetting binding of erythrocytes in Plasmodium falciparum malaria. Infect. Immun. 66 (1998) 2969-2975
18. Cockburn I.A., Mackinnon M.J., O'Donnell A., Allen S.J., Moulds J.M., Baisor M., Bockarie M., Reeder J.C., and Rowe J.A. A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 272-278
19. Carlson J., and Wahlgren M. Plasmodium falciparum erythrocyte rosetting is mediated by promiscuous lectin-like interactions. J. Exp. Med. 176 (1992) 1311-1317
20. Barragan A., Kremsner P.G., Wahlgren M., and Carlson J. Blood group A antigen is a coreceptor in Plasmodium falciparum resetting. Infect. Immun. 68 (2000) 2971-2975
21. Chung W.Y., Gardiner D.L., Hyland C., Gatton M., Kemp D.J., and Trenholme K.R. Enhanced invasion of blood group A1 erythrocytes by Plasmodium falciparum. Mol. Biochem. Parasitol. 144 (2005) 128-309
22. Bull P.C., Lowe B.S., Kortok M., and Marsh K. Antibody recognition of Plasmodium falciparum erythrocyte surface antigens in Kenya: evidence for rare and prevalent variants. Infect. Immun. 67 (1999) 733-739
23. Bull P.C., Lowe B.S., Kaleli N., Njuga F., Kortok M., Ross A., Ndungu F., Snow R.W., and Marsh K. Plasmodium falciparum infections are associated with agglutinating antibodies to parasite-infected erythrocyte surface antigens among healthy Kenyan children. J. Infect. Dis. 185 (2002) 1688-1691
24. Nielsen M.A., Staalsoe T., Kurtzhals J.A., Goka B.Q., Dodoo D., Alifrangis M., Theander T.G., Akanmori B.D., and Hviid L. Plasmodium falciparum variant surface antigen expression varies between isolates causing severe and nonsevere malaria and is modified by acquired immunity. J. Immunol. 168 (2002) 3444-3450
25. Wahlgren M., Carlson J., Ruangjirachuporn W., Conway D., Helmby H., Martinez A., Patarroyo M.E., and Riley E. Geographical distribution of Plasmodium falciparum erythrocyte rosetting and frequency of rosetting antibodies in human sera. Am. J. Trop. Med. Hyg. 43 (1990) 333-338
26. Nielsen M.A., Vestergaard L.S., Lusingu J., Kurtzhals J.A., Giha H.A., Grevstad B., Goka B.Q., Lemnge M.M., Jensen J.B., Akanmori B.D., Theander T.G., Staalsoe T., and Hviid L. Geographical and temporal conservation of antibody recognition of Plasmodium falciparum variant surface antigens. Infect. Immun. 72 (2004) 3531-3535
27. Barragan A., Kremsner P.G., Weiss W., Wahlgren M., and Carlson J. Age-related buildup of humoral immunity against epitopes for rosette formation and agglutination in African areas of malaria endemicity. Infect. Immun. 66 (1998) 4783-4787
28. Jensen A.T., Magistrado P., Sharp S., Joergensen L., Lavstsen T., Chiucchiuini A., Salanti A., Vestergaard L.S., Lusingu J.P., Hermsen R., Sauerwein R., Christensen J., Nielsen M.A., Hviid L., Sutherland C., Staalsoe T., and Theander T.G. Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes. J. Exp. Med. 199 (2004) 1179-1190
29. Rasti N., Wahlgren M., and Chen Q. Molecular aspects of malaria pathogenesis. FEMS Immunol. Med. Microbiol. 41 (2004) 9-26
30. Gaur D., Ghislaine Mayer D.C., and Miller L.H. Parasite ligand-host receptor interactions during invasion of erythrocytes by Plasmodium merozoites. Int. J. Parasitol. 34 (2004) 1413-1429
31. Baum J., Maier A.G., Good R.T., Simpson K.M., and Cowman A.F. Invasion by P. falciparum merozoites suggests a hierarchy of molecular interactions. PLoS Pathog. 1 (2005) e37
32. Flick K., and Chen Q. var genes, PfEMP1 and the human host. Mol. Biochem. Parasitol. 134 (2004) 3-9
33. Peters J., Fowler E., Gatton M., Chen N., Saul A., and Cheng Q. High diversity and rapid changeover of expressed var genes during the acute phase of Plasmodium falciparum infections in human volunteers. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 10689-10694
34. Lavstsen T., Magistrado P., Hermsen C.C., Salanti A., Jensen A.T., Sauerwein R., Hviid L., Theander T.G., and Staalsoe T. Expression of Plasmodium falciparum erythrocyte membrane protein 1 in experimentally infected humans. Malar. J. 4 (2005) 21
35. Kaestli M., Cortes A., Lagog M., Ott M., and Beck H.P. Longitudinal assessment of Plasmodium falciparum var gene transcription in naturally infected asymptomatic children in Papua New Guinea. J. Infect. Dis. 189 (2004) 1942-1951
36. Kirchgatter K., and Portillo Hdel A. Association of severe noncerebral Plasmodium falciparum malaria in Brazil with expressed PfEMP1 DBL1 alpha sequences lacking cysteine residues. Mol. Med. 8 (2002) 16-23
37. Bull P.C., Berriman M., Kyes S., Quail M.A., Hall N., Kortok M.M., Marsh K., and Newbold C.I. Plasmodium falciparum variant surface antigen expression patterns during malaria. PLoS Pathog. 1 (2005) e26
38. Baruch D.I., Gamain B., Barnwell J.W., Sullivan J.S., Stowers A., Galland G.G., Miller L.H., and Collins W.E. Immunization of Aotus monkeys with a functional domain of the Plasmodium falciparum variant antigen induces protection against a lethal parasite line. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 3860-3865
39. Chen Q., Pettersson F., Vogt A.M., Schmidt B., Ahuja S., Liljestrom P., and Wahlgren M. Immunization with PfEMP1-DBL1alpha generates antibodies that disrupt rosettes and protect against the sequestration of Plasmodium falciparum-infected erythrocytes. Vaccine 22 (2004) 2701-2712
40. Urban B.C., Ferguson D.J., Pain A., Willcox N., Plebanski M., Austyn J.M., and Roberts D.J. Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 400 (1999) 73-77
41. Urban B.C., Willcox N., and Roberts D.J. A role for CD36 in the regulation of dendritic cell function. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 8750-8755
42. Urban B.C., Ing R., and Stevenson M.M. Early interactions between blood-stage plasmodium parasites and the immune system. Curr. Top. Microbiol. Immunol. 297 (2005) 25-70
43. Dorfman J.R., Bejon P., Ndungu F.M., Langhorne J., Kortok M.M., Lowe B.S., Mwangi T.W., Williams T.N., and Marsh K. B cell memory to 3 Plasmodium falciparum blood-stage antigens in a malaria-endemic area. J. Infect. Dis. 191 (2005) 1623-1630
44. Donati D., Zhang L.P., Chen Q., Chene A., Flick K., Nystrom M., Wahlgren M., and Bejarano M.T. Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infect. Immun. 72 (2004) 5412-5418
45. Donati D., Mok B., Chêne A., Xu H., Thangarajh M., Glas R., Chen Q., Wahlgren M., and Bejarano M.T. Increased B cell survival and preferential activation of the memory compartment by a malaria polyclonal B cell activator. J. Immunol. 177 (2006) 3035-3044
46. Cohen S., Mcgregor I.A., and Carrington S. Gamma-globulin and acquired immunity to human malaria. Nature 192 (1961) 733-737
47. Sabchareon A., Burnouf T., Ouattara D., Attanath P., Bouharoun-Tayoun H., Chantavanich P., Foucault C., Chongsuphajaisiddhi T., and Druilhe P. Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am. J. Trop. Med. Hyg. 45 (1991) 297-308
48. Marsh K., Otoo L., Hayes R.J., Carson D.C., and Greenwood B.M. Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans. R. Soc. Trop. Med. Hyg. 83 (1989) 293-303
49. Flick K., Scholander C., Chen Q., Fernandez V., Pouvelle B., Gysin J., and Wahlgren M. Role of nonimmune IgG bound to PfEMP1 in placental malaria. Science 293 (2001) 2098-2100
50. K. Moll, F. Pettersson, A.M. Vogt, C. Jonsson, N. Rasti, S. Ahuja, M. Spångberg, O. Mercereau-Puijalon, D.E. Arnot, M. Wahlgren, Q. Chen, Generation of cross-protective antibodies against Plasmodium falciparum sequestration by immunization with a PfEMP1-DBL1α-domain, Infect. Immun. 75 (2007) 211-219.
51. Gratepanche S., Gamain B., Smith J.D., Robinson B.A., Saul A., and Miller L.H. Induction of crossreactive antibodies against the Plasmodium falciparum variant protein. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 13007-13012